We investigated serum levels of interleukin (IL)-1 beta, IL-6, IL-8, IL-12
and tumour necrosis factor (TNF)-alpha in JRA patients during both active a
nd inactive phases of the disease. The systemic JRA patients had the highes
t IL-1 beta and IL-6 levels during both active and inactive periods. In the
systemic group IL-1 beta, IL-6 and IL-12 levels during the active period w
ere elevated compared to the inactive period (p = 0.0173, p = 0.0359 and p
= 0.0117, respectively). Levels of these cytokines during the inactive stag
e were still greater than those of controls. IL-8 and TNF-alpha. levels dur
ing both active and inactive periods were comparable to controls. IL-1 beta
correlated strongly with CRP and ESR (p = 0.008 and p = 0.031, respectivel
y). IL-6 correlated significantly with CRP (p = 0.002). IL-12 levels were f
ound to be correlated with ESR and CRP (p = 0.03 and p = 0.04, respectively
). In active polyarticular JRA patients, IL-6 levels were elevated compared
to the inactive phase, and the control (p = 0.001) IL-12 levels decreased
significantly with clinical remission (p = 0.018). There was a strong corre
lation between Il-12 levels and number of joint with limited motion (p = 0)
. In oligoarticular JRA patients, IL-12 levels during active period were gr
eater than in the controls and there was a marked decrease in IL-12 levels
when the patients entered the inactive phase (p = 0.001) In conclusion, IL-
1 beta, IL-6 and IL-12 may play an important role in JRA and may be used as
a marker of disease activity.